NCT03987958Active, not recruiting
A Study to Describe the Safety and Effectiveness of Venetoclax in Acute Myeloid Leukemia (AML) Patients (REVIVE Study)
Prospective Non-interventional Study to Describe the Effectiveness and Safety of Venetoclax in Acute Myeloid Leukemia (AML) Patients in Routine Clinical Practice (REVIVE Study)
Source: ClinicalTrials.gov · Last updated 16 Jan 2026
Brief summary (registry, in English)
This study will describe the safety and effectiveness of venetoclax in AML patients in routine clinical practice in Israel. The decision to treat with venetoclax is made by the physician prior to any decision regarding participation in this study.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 14 Jun 2019
- Start date
- 8 Aug 2019
- Primary completion date
- Jul 2027
- Lead sponsor
- AbbVie
- Diseases
- Acute myeloid leukemia
- NCT number
- NCT03987958
What you commit to
- Study type: Observational
- Planned participants: 100
- From 8 Aug 2019 to the primary completion date, Jul 2027
- 12 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- \- Participant participating in an interventional trial within 30 days prior to starting venetoclax treatment.
Who the study is looking for
- Participant diagnosed with Acute Myeloid Leukemia (AML) and is eligible to receive venetoclax per Israel Ministry of Health.
- Participant who will be treated with venetoclax and the decision to treat with venetoclax is made by the physician prior to any decision regarding participation in this study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (12)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| HaEmek Medical Center /ID# 213370 Coordinator of this site? Confirm its status | Afula | Israel | Unknown status |
| Soroka University Medical Center /ID# 213369 Coordinator of this site? Confirm its status | Beersheba | Israel | Unknown status |
| Bnai Zion Medical Center /ID# 213344 Coordinator of this site? Confirm its status | Haifa | Israel | Unknown status |
| Rambam Health Care Campus /ID# 213355 Coordinator of this site? Confirm its status | Haifa | Israel | Unknown status |
| Shaare Zedek Medical Center /ID# 228016 Coordinator of this site? Confirm its status | Jerusalem | Israel | Unknown status |
| Hadassah /ID# 213356 Coordinator of this site? Confirm its status | Jerusalem | Israel | Unknown status |
| Meir Medical Center /ID# 213352 Coordinator of this site? Confirm its status | Kfar Saba | Israel | Unknown status |
| Rabin Medical Center. /ID# 213343 Coordinator of this site? Confirm its status | Petah Tikva | Israel | Unknown status |
| The Chaim Sheba Medical Center /ID# 213353 Coordinator of this site? Confirm its status | Ramat Gan | Israel | Unknown status |
| ZIV Medical Center /ID# 229211 Coordinator of this site? Confirm its status | Safed | Israel | Unknown status |
| Tel Aviv Sourasky Medical Center /ID# 213354 Coordinator of this site? Confirm its status | Tel Aviv | Israel | Unknown status |
| Assuta Tel Aviv Medical Center /ID# 213371 Coordinator of this site? Confirm its status | Tel Aviv | Israel | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.